ArticleAnnals of medicine and surgery (2012)2025
Tiny sensors, big hope: ML-optimized nanodiagnostics for TBI in Sanfilippo syndrome.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sanfilippo syndrome (mucopolysaccharidosis type III) is a rare autosomal recessive disorder marked by neurodegeneration due to defective heparan sulfate metabolism. Diagnostic and therapeutic limitations persist, particularly for detecting comorbid conditions like traumatic brain injury (TBI), which requires sensitive, rapid tools for timely intervention. Emerging ML-optimized nanodiagnostic platforms offer a breakthrough, allowing early-stage, high-fidelity detection of TBI biomarkers in biofluids. Recent studies employing surface-enhanced Raman spectroscopy (SERS) and multiplex electrochemiluminescence (ECL) sensors demonstrate the capacity for real-time, low-volume, point-of-care TBI diagnosis. However, limitations remain in adapting these models for rare pediatric populations due to data scarcity, blood-brain barrier constraints, and biomarker kinetics. We call for expanded validation, interdisciplinary collaboration, and the development of wearable diagnostics to personalize care and improve outcomes in Sanfilippo syndrome and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.